Afya Limited (NASDAQ:AFYA) Stock Rated "Hold" by Wall Street Brokerages

Key Points

• Afya has a “Hold” consensus rating: Five of seven analysts recommend holding the stock, versus one sell and one buy, with an average 12-month price target of $17.75.
• The proposed merger with Yduqs could create a Brazilian higher-education platform serving about 1.6 million students, with Afya shareholders expected to own roughly 69.3%. Potential synergies and dividends may support the deal, but regulatory approval, integration, and possible Nasdaq delisting remain risks.
• Afya’s latest quarterly results exceeded earnings expectations, reporting $0.43 in EPS versus the $0.40 consensus, although revenue of $187.8 million fell slightly short of estimates.

Afya Limited (NASDAQ:AFYA - Get Free Report) has been assigned an average recommendation of "Hold" from the seven ratings firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $17.75.

Several research analysts have commented on the company. JPMorgan Chase & Co. dropped their price target on Afya from $21.50 to $21.00 and set a "neutral" rating on the stock in a research report on Monday, June 22nd. Wall Street Zen raised Afya from a "hold" rating to a "buy" rating in a research report on Saturday, September 5th. Weiss Ratings lowered shares of Afya from a "hold (c)" rating to a "hold (c-)" rating in a research report on Friday, July 31st. Zacks Research cut shares of Afya from a "hold" rating to a "strong sell" rating in a research note on Friday, August 21st. Finally, Bank of America reiterated a "neutral" rating on shares of Afya in a research note on Thursday, June 11th.

Afya News Roundup

Here are the key news stories impacting Afya this week:

• Positive Sentiment: Binding merger agreement announced: Afya and Yduqs agreed to combine their Brazilian higher-education operations, creating a platform with approximately 1.6 million students and reported annual revenue of about R$9.4 billion. Afya shareholders are expected to own roughly 69.3% of the combined company. Afya Limited and Yduqs Enter Into Merger Agreement
• Positive Sentiment: Potential scale and cash-flow benefits: Management says the combination could accelerate cash generation and support further consolidation in Brazil’s education market. Reports citing JPMorgan have discussed potential synergies of up to R$2.8 billion, though investors should treat that figure as an analyst scenario rather than guaranteed savings. JPMorgan Synergy Scenarios
• Positive Sentiment: Potential shareholder distribution: The reported transaction structure includes approximately R$750 million in dividends, which may support sentiment toward Afya’s shareholders if confirmed and completed. Afya-Yduqs Merger and Dividends
• Neutral Sentiment: Short-interest data is inconsistent: One report showed short interest rising 163.2% to 1.41 million shares, equivalent to 5.2 days to cover, while another reported zero shares short. The conflicting figures reduce the reliability of this signal, although the higher estimate could create volatility or short-covering pressure.
• Negative Sentiment: Merger risks remain: The deal requires customary approvals and successful integration. Reports also suggest Afya could leave Nasdaq while the combined company remains listed on Brazil’s B3, potentially affecting U.S. trading liquidity and investor access. Afya to Merge With Yduqs
• Negative Sentiment: Analyst caution: Zacks added AFYA to its Rank #5 “Strong Sell” list, providing a counterweight to the merger-related optimism.

Afya Stock Up 1.1%

AFYA stock opened at $13.73 on Friday. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of 8.37, a price-to-earnings-growth ratio of 1.51 and a beta of 0.35. The company has a 50-day moving average of $14.01 and a two-hundred day moving average of $14.34. Afya has a 52-week low of $13.00 and a 52-week high of $16.43. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20.

Afya (NASDAQ:AFYA - Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%.The business had revenue of $187.80 million for the quarter, compared to analyst estimates of $189.62 million. As a group, equities research analysts anticipate that Afya will post 1.86 EPS for the current year.

Insider Activity at Afya

In other news, VP Lélio de Souza, Jr. sold 36,204 shares of the company's stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total transaction of $543,060.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.80% of the company's stock.

Institutional Investors Weigh In On Afya

Institutional investors have recently added to or reduced their stakes in the company. Swedbank AB increased its stake in Afya by 170.3% during the fourth quarter. Swedbank AB now owns 189,200 shares of the company's stock valued at $2,916,000 after acquiring an additional 119,200 shares during the period. Engineers Gate Manager LP bought a new stake in shares of Afya in the 2nd quarter worth approximately $325,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Afya during the 2nd quarter worth approximately $67,000. Finally, Banco BTG Pactual S.A. acquired a new stake in shares of Afya during the 4th quarter worth approximately $462,000. 88.02% of the stock is owned by institutional investors and hedge funds.

About Afya

Afya Limited is a Brazilian medical education and technology company that operates an integrated platform for physicians and medical students. The company provides education and professional development throughout the medical career cycle, from undergraduate training and residency preparation to continuing medical education and specialization programs.

Afya's offerings include medical schools, preparatory courses, postgraduate and continuing education programs, digital learning tools, and clinical practice technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.